Looking to publish in BioDrugs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginBioDrugs is a hybrid journal covering the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease, serving R&D professionals and clinicians interested in biologic therapies.
Looking to publish in BioDrugs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
BioDrugs accepts the following article types. Click on an article type to view submission instructions.
Review Article
Systematic Review
Original Research
Narrative Reviews
Meta-Analysis
Summary Of Research Articles (Sras)
Letter To The Editor
Recent Publications
From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate
Björn Capsius, Marija Pesic, Ravil Niyazov, Susanne Pippig, Michael Trieb, Rahul Hole, Sigrid Balser, Andreas Seidl
Plant-Based Systems for Producing Therapeutic Proteins: Current Status and Future Prospects
Qiang Chen
Biosimilars: A Virtuous Cycle of Sustainability and Innovation
Fernando de Mora, Vicente Merino-Bohórquez, Rosario García-Vicuña, Isabel Río-Álvarez
Biologic Therapies for Alleviating Neurodegeneration in Lysosomal Storage Diseases
Liyan Qiu, Jonas Torbjörn Ungerbäck, Eric Paul Bennett, Rasmus O. Bak
Beyond the Prevention of Anti-drug Antibody Formation with Uricase Therapy: Mechanistic Roles of DMARDs in Modifying Gout Flare Risk
Ted R. Mikuls, Tuhina Neogi, Angelo Gaffo
Frequently asked questions
How long does it take to publish?
Accepted articles are published online after receipt of the corrected proofs.
Reformat to BioDrugs using Livewrite PremiumIs a cover letter required?
A cover letter is used when unpublished material is included in the manuscript and when suggesting reviewers the corresponding author should include reviewer identity details in the submission letter.
Reformat to BioDrugs using Livewrite PremiumWhat are the publication costs?
Open access APC: £3790.00 GBP / $5490.00 USD / €4490.00 EUR. Subscription publishing has no APC charges.
Reformat to BioDrugs using Livewrite Premium